PPARα in the pathogenesis of fatty liver disease
Open Access
- 1 October 2004
- journal article
- editorial
- Published by Wolters Kluwer Health in Hepatology
- Vol. 40 (4) , 783-786
- https://doi.org/10.1002/hep.1840400405
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Peroxisome proliferator-activated receptor ? protects against alcohol-induced liver damageHepatology, 2004
- Transcription Coactivator PBP, the Peroxisome Proliferator-activated Receptor (PPAR)-binding Protein, Is Required for PPARα-regulated Gene Expression in LiverJournal of Biological Chemistry, 2004
- Administration of the potent PPARα agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in miceHepatology, 2004
- Non-alcoholic fatty liver disease: an emerging pathological spectrumVirchows Archiv, 2004
- Central Role of Pparα–Dependent Hepatic Lipid Turnover in Dietary Steatohepatitis in MiceHepatology, 2003
- SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liverJournal of Clinical Investigation, 2002
- PPARγ: a Nuclear Regulator of Metabolism, Differentiation, and Cell GrowthJournal of Biological Chemistry, 2001
- Defect in Peroxisome Proliferator-activated Receptor α-inducible Fatty Acid Oxidation Determines the Severity of Hepatic Steatosis in Response to FastingJournal of Biological Chemistry, 2000
- Peroxisome proliferator–activated receptor α mediates the adaptive response to fastingJournal of Clinical Investigation, 1999
- Ethanol-induced liver fibrosis in rats fed high fat dietHepatology, 1986